Thomas Jurgensen
Directeur Général chez Catalyst Law Group, APC
Fortune : 38 743 $ au 30/04/2024
Profil
Thomas E.
Jurgensen is the founder of Inverseon, Inc. (founded in 2004) and Allylix, Inc. (founded in 2002).
At Allylix, he held the title of Chairman from 2002 to 2009.
He is also the founder of Catalyst Law Group, APC.
Currently, he is a Director at Live, Give, Save, Inc. In the past, he worked as Secretary & Director at CLC Entertainment Studios, Inc., Secretary, Vice President & General Counsel at Molecular Biosystems, Inc., and Associate General Counsel at Ligand Pharmaceuticals, Inc. He also worked as Vice President & General Counsel at The Salk Institute for Biological Studies from 1999 to 2000.
He was an Associate Attorney at Merchant & Gould PC and an Intellectual Property Counsel at 3M Corp.
He received his graduate degree from Iowa State University in 1985, his undergraduate degree from the University of Wisconsin in 1981, and his graduate degree from the University of Oregon in 1989.
From 2021 to 2023, he will be serving as Secretary & General Counsel at Organovo Holdings, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ORGANOVO HOLDINGS, INC.
0,34% | 17/11/2023 | 39 214 ( 0,34% ) | 38 743 $ | 30/04/2024 |
Postes actifs de Thomas Jurgensen
| Sociétés | Poste | Début |
|---|---|---|
| Catalyst Law Group, APC | Directeur Général | 05/04/2010 |
Live, Give, Save, Inc.
 Live, Give, Save, Inc. Packaged SoftwareTechnology Services Live, Give, Save, Inc. is a financial technology company. It integrates budgeting, savings, investment, and giving in an all-in-one financial application that enables anyone to use everyday purchases to increase savings as well as give to causes. The company was founded by Susan Langer and Ajay Nair in 2016 and is headquartered in Red Wing, MN. | Directeur/Membre du Conseil | - |
Anciens postes connus de Thomas Jurgensen
| Sociétés | Poste | Fin |
|---|---|---|
| ORGANOVO HOLDINGS, INC. | Directeur Financier/CFO | 13/05/2021 |
Inverseon, Inc.
 Inverseon, Inc. Pharmaceuticals: MajorHealth Technology Inverseon, Inc. is a private company developing a re-profiled beta blocker for the treatment of asthma and COPD. Inverseon’s scientific approach, “Paradoxical Pharmacology”, is based on observations that chronic effects of inverse agonist drugs are completely opposite to their acute effects. A similar paradigm shift occurred in the late 1990’s with the approval of the first beta blocker for congestive heart failure, a disease state where the drug was also originally contraindicated. Inverseon’s scientific founder, Professor Richard Bond, identified the mechanism of action as inverse agonism at the beta adrenergic receptor and hypothesized that this observation represented a general pharmacological phenomenon and identified asthma as another disease to target. To date, the company has achieved a number of important milestones: completing two open-label Phase 2a studies demonstrating a dose-response, a comment in The Lancet in 2009 highlighting the published human clinical trial, and 2009 issuance of their first U.S. patent. | Fondateur | 01/09/2012 |
| The Salk Institute for Biological Studies | Conseiller Juridique Général | 01/12/2000 |
CLC Entertainment Studios, Inc.
 CLC Entertainment Studios, Inc. Movies/EntertainmentConsumer Services CLC Entertainment Studios, Inc. develops, produces, and distributes entertainment projects in the areas of film, television, and Broadway plays. The company was founded by Cathy Lee Crosby and is headquartered in Santa Monica, CA. | Directeur/Membre du Conseil | - |
Merchant & Gould PC
 Merchant & Gould PC Miscellaneous Commercial ServicesCommercial Services Merchant & Gould PC provides legal services. It focuses on appellate, licensing, litigation, mechanical, copyright, and trademarks. The company was founded in 1900 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
Formation de Thomas Jurgensen
| Iowa State University | Graduate Degree |
| University of Wisconsin | Undergraduate Degree |
| University of Oregon | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| ORGANOVO HOLDINGS, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Molecular Biosystems, Inc.
 Molecular Biosystems, Inc. Medical SpecialtiesHealth Technology Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA. | Health Technology |
Allylix, Inc.
 Allylix, Inc. Pharmaceuticals: OtherHealth Technology Allylix, Inc. develops terpene products for flavor and fragrance, food ingredients, pharmaceuticals, agricultural, and biofuels markets. The company was founded by Joseph Chappel, Thomas E. Jurgensen, and Joseph Noel on January 4, 2005 and is headquartered in Lexington, KY. | Health Technology |
CLC Entertainment Studios, Inc.
CLC Entertainment Studios, Inc. Movies/EntertainmentConsumer Services CLC Entertainment Studios, Inc. develops, produces, and distributes entertainment projects in the areas of film, television, and Broadway plays. The company was founded by Cathy Lee Crosby and is headquartered in Santa Monica, CA. | Consumer Services |
Merchant & Gould PC
Merchant & Gould PC Miscellaneous Commercial ServicesCommercial Services Merchant & Gould PC provides legal services. It focuses on appellate, licensing, litigation, mechanical, copyright, and trademarks. The company was founded in 1900 and is headquartered in Minneapolis, MN. | Commercial Services |
| 3M Corp. /Orthopedic Implants Business/ | Health Technology |
Inverseon, Inc.
Inverseon, Inc. Pharmaceuticals: MajorHealth Technology Inverseon, Inc. is a private company developing a re-profiled beta blocker for the treatment of asthma and COPD. Inverseon’s scientific approach, “Paradoxical Pharmacology”, is based on observations that chronic effects of inverse agonist drugs are completely opposite to their acute effects. A similar paradigm shift occurred in the late 1990’s with the approval of the first beta blocker for congestive heart failure, a disease state where the drug was also originally contraindicated. Inverseon’s scientific founder, Professor Richard Bond, identified the mechanism of action as inverse agonism at the beta adrenergic receptor and hypothesized that this observation represented a general pharmacological phenomenon and identified asthma as another disease to target. To date, the company has achieved a number of important milestones: completing two open-label Phase 2a studies demonstrating a dose-response, a comment in The Lancet in 2009 highlighting the published human clinical trial, and 2009 issuance of their first U.S. patent. | Health Technology |
| Catalyst Law Group, APC | |
Live, Give, Save, Inc.
Live, Give, Save, Inc. Packaged SoftwareTechnology Services Live, Give, Save, Inc. is a financial technology company. It integrates budgeting, savings, investment, and giving in an all-in-one financial application that enables anyone to use everyday purchases to increase savings as well as give to causes. The company was founded by Susan Langer and Ajay Nair in 2016 and is headquartered in Red Wing, MN. | Technology Services |